CN Patent

CN112888691B — 吡咯并[2,3-d]嘧啶甲苯磺酸盐、其结晶形式以及有关的制备方法和中间体

Assigned to Pfizer Inc · Expires 2023-10-31 · 3y expired

What this patent protects

本发明公开了1‑((2S,5R)‑5‑((7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)‑2‑甲基哌啶‑1‑基)丙‑2‑烯‑1‑酮的新的对甲苯磺酸盐和所述盐的结晶多晶型形式1，含有它们的药物组合物，以及其制备及用途。本发明也公开了1‑((2S,5R)‑5‑((7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)‑2‑甲基哌啶‑1‑基)丙‑2‑烯‑1‑酮的新的磷酸盐，含有它们的药物组合物，以及其制备及用途。

USPTO Abstract

本发明公开了1‑((2S,5R)‑5‑((7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)‑2‑甲基哌啶‑1‑基)丙‑2‑烯‑1‑酮的新的对甲苯磺酸盐和所述盐的结晶多晶型形式1，含有它们的药物组合物，以及其制备及用途。本发明也公开了1‑((2S,5R)‑5‑((7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)‑2‑甲基哌啶‑1‑基)丙‑2‑烯‑1‑酮的新的磷酸盐，含有它们的药物组合物，以及其制备及用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN112888691B
Jurisdiction
CN
Classification
—
Expires
2023-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.